Malaria

37 treatments and conditions followed through the public trial records. Not medical advice.How a status is set

Lists this condition and the narrower ones beneath it. A condition is not a diagnosis.

Treatments and conditions

Malaria
Treatment and conditionWhere it standsTrials
"Synchronised" arm (intervention) for malariaPhase 3 trial, as of 19 Nov 2026 (not yet checked by a person)1
Artemether + Lumefantrine for malaria, vivaxPhase 1 trial, as of 19 Nov 2026 (not yet checked by a person)1
Artemether + Lumefantrine + TAFENOQUINE for malaria, vivaxPhase 1 trial, as of 19 Nov 2026 (not yet checked by a person)1
artemether-lumefantrine for malaria, falciparumTrial registered, as of 19 Nov 2026 (not yet checked by a person)1
artemether-lumefantrine + Mosquirixs for malaria, falciparumTrial registered, as of 19 Nov 2026 (not yet checked by a person)1
Atovaquone-Proguanil for malaria, falciparumPhase 2 trial, as of 19 Nov 2026 (not yet checked by a person)1
Cabamiquine for malaria, falciparumPhase 1 trial, as of 19 Nov 2026 (not yet checked by a person)1
Coartem® Baby for malariaTrial registered, as of 19 Nov 2026 (not yet checked by a person)1
Dihydroartemisinin + Piperaquine tetraphosphate for malaria, vivaxPhase 1 trial, as of 19 Nov 2026 (not yet checked by a person)1
Dihydroartemisinin + Piperaquine tetraphosphate + TAFENOQUINE for malaria, vivaxPhase 1 trial, as of 19 Nov 2026 (not yet checked by a person)1
Dihydroartemisinin-Piperaquine (DP) for malariaPhase 3 trial, as of 19 Nov 2026 (not yet checked by a person)1
Etofenprox-treated lesu for malaria, falciparumTrial registered, as of 19 Nov 2026 (not yet checked by a person)1
Factory-treated lesu for malaria, falciparumTrial registered, as of 19 Nov 2026 (not yet checked by a person)1
GSK malaria vaccine 257049 Vaccine for malariaPhase 2 trial, as of 19 Nov 2026 (not yet checked by a person)1
Ivermectin for malariaPhase 3 trial, as of 19 Nov 2026 (not yet checked by a person)2
M5717 200 mg + PYRONARIDINE for malaria, falciparumPhase 2 trial, as of 19 Nov 2026 (not yet checked by a person)1
M5717 330 mg + PYRONARIDINE for malaria, falciparumPhase 2 trial, as of 19 Nov 2026 (not yet checked by a person)1
M5717 500 mg + M5717 660 mg + PYRONARIDINE for malaria, falciparumPhase 2 trial, as of 19 Nov 2026 (not yet checked by a person)1
M5717 60 mg + PYRONARIDINE for malaria, falciparumPhase 2 trial, as of 19 Nov 2026 (not yet checked by a person)1
M5717 660mg + PYRONARIDINE for malaria, falciparumPhase 2 trial, as of 19 Nov 2026 (not yet checked by a person)1
Malaria Vaccine 257049 for malariaPhase 3 trial, as of 19 Nov 2026 (not yet checked by a person)1
Malaria Vaccine 257049 + Polio Sabin Oral Polio Vaccine (GSK) + TritanrixHepB/Hib for malariaPhase 3 trial, as of 19 Nov 2026 (not yet checked by a person)1
Matrix-M with RH5.2 VLP and/or R21 for malaria, falciparumPhase 1 trial, as of 19 Nov 2026 (not yet checked by a person)1
Methylenblue for malariaPhase 2 trial, as of 19 Nov 2026 (not yet checked by a person)1
Mosquirixs for malaria, falciparumTrial registered, as of 19 Nov 2026 (not yet checked by a person)1
Permethrin-treated lesu for malariaTrial registered, as of 19 Nov 2026 (not yet checked by a person)1
Permethrin-treated lesu for malaria, falciparumTrial registered, as of 19 Nov 2026 (not yet checked by a person)1
Polio Sabin Oral Polio Vaccine (GSK) + TritanrixHepB/Hib for malariaPhase 3 trial, as of 19 Nov 2026 (not yet checked by a person)1
Primaquine for malaria, vivaxPhase 3 trial, as of 19 Nov 2026 (not yet checked by a person)2
Pvs230D1-EPA/Matrix-M for malaria, vivaxTrial registered, as of 19 Nov 2026 (not yet checked by a person)1
R21 in Matrix- M adjuvant vaccine for malaria, falciparumPhase 1 trial, as of 19 Nov 2026 (not yet checked by a person)1
R21/Matrix-M - single vial formulation for malariaPhase 1 trial, as of 19 Nov 2026 (not yet checked by a person)1
R21/Matrix-M - two vial formulation for malariaPhase 1 trial, as of 19 Nov 2026 (not yet checked by a person)1
Soaked lesu for malaria, falciparumTrial registered, as of 19 Nov 2026 (not yet checked by a person)1
Tafenoquine for malaria, vivaxPhase 3 trial, as of 19 Nov 2026 (not yet checked by a person)6
Tafenoquine + chloroquine for malaria, vivaxPhase 2 trial, as of 19 Nov 2026 (not yet checked by a person)1
Tafenoquine succinate for malaria, vivaxPhase 3 trial, as of 19 Nov 2026 (not yet checked by a person)1